NOD2 and kidney cancer: The NOD2 expressive level seemed to be an adverse event for the survival of kidney cancer patients in KIPAN and KIRC database, which is obvious in Figure 1A and Figure 1C ,while a box plot across risk groups in Figure 1B and Figure 1D also showed the similar approval testimony.